Characterization of the Glycosaminoglycan-binding Region of Lactoferrin
Overview
Biophysics
Authors
Affiliations
Lactoferrin is a prominent component of neutrophil secondary granules and its blood concentration is increased in certain inflammatory diseases. Although the biochemical characterization of lactoferrin as an iron-binding protein has been well described, its physiological role in inflammation remains undefined. We examined the ability of lactoferrin to regulate glycosaminoglycan-accelerated thrombin-serine protease inhibitor (serpin) reactions. Lactoferrin effectively reduced the rate of thrombin-serpin (antithrombin and heparin cofactor II) reactions by three physiological glycosamino-glycans including heparin, heparan sulfate, and dermatan sulfate. An enzyme kinetics analysis showed that lactoferrin did not alter the apparent heparin-thrombin or the heparin-antithrombin dissociation constant values for the heparin-catalyzed thrombin-antithrombin reaction. However, the maximum reaction velocity at saturation with respect to either protein was markedly decreased by lactoferrin. The glycosaminoglycan-binding region of lactoferrin was analyzed following limited proteolysis using Staphylococcus aureus V8 protease. Two lactoferrin fragments with Mr's of approximately 8 and approximately 11 kDa were purified based on their affinity to heparin-Sepharose. Amino acid sequence analysis demonstrated that both peptides were from the N-terminus. Although slightly less capable compared to intact lactoferrin, the lactoferrin peptides effectively neutralized heparin, heparan sulfate, and dermatan sulfate-catalyzed serpin-thrombin inhibition reactions. In addition, lactoferrin N-terminal peptides have approximately the same binding affinity to heparin-Sepharose as that of intact lactoferrin. Inspection of both the N-terminal amino acid sequence and the crystal structure of lactoferrin further supports the conclusion that lactoferrin is a novel glycosaminoglycan binding protein and that the putative glycosaminoglycan-binding site is localized to the N-terminus.
Lactoferrins in Their Interactions with Molecular Targets: A Structure-Based Overview.
Piacentini R, Boffi A, Milanetti E Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543184 PMC: 10974892. DOI: 10.3390/ph17030398.
Milk Antiviral Proteins and Derived Peptides against Zoonoses.
Santos I, Silva M, Gracio M, Pedroso L, Lima A Int J Mol Sci. 2024; 25(3).
PMID: 38339120 PMC: 10855762. DOI: 10.3390/ijms25031842.
Rosa L, Cutone A, Conte M, Campione E, Bianchi L, Valenti P Biometals. 2022; 36(3):417-436.
PMID: 35920949 PMC: 9362590. DOI: 10.1007/s10534-022-00427-z.
Suggestions on leading an academic research laboratory group.
Church F Open Life Sci. 2022; 17(1):599-609.
PMID: 35800075 PMC: 9202531. DOI: 10.1515/biol-2022-0061.
Advances in Targeting HPV Infection as Potential Alternative Prophylactic Means.
Carse S, Bergant M, Schafer G Int J Mol Sci. 2021; 22(4).
PMID: 33672181 PMC: 7926419. DOI: 10.3390/ijms22042201.